GSK plc (LON: GSK)
1,504.00
+0.50 (0.03%)
Jul 3, 2024, 8:45 AM GMT
GSK plc Revenue
GSK plc had revenue of 30.74B GBP in the twelve months ending March 31, 2024, with 5.69% growth year-over-year. Revenue in the quarter ending March 31, 2024 was 7.36B GBP with 5.93% year-over-year growth. In the year 2023, GSK plc had annual revenue of 30.33B GBP with 3.42% growth.
Revenue (ttm)
30.74B
Revenue Growth
+5.69%
P/S Ratio
1.99
Revenue / Employee
437,817
Employees
70,212
Market Cap
61.33B GBP
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
Dec 31, 2022 | 29.32B | -4.79B | -14.04% |
Dec 31, 2021 | 34.11B | 15.00M | 0.04% |
Dec 31, 2020 | 34.10B | 345.00M | 1.02% |
Dec 31, 2019 | 33.75B | 2.93B | 9.52% |
Dec 31, 2018 | 30.82B | 635.00M | 2.10% |
Dec 31, 2017 | 30.19B | 2.30B | 8.24% |
Dec 31, 2016 | 27.89B | 3.97B | 16.58% |
Dec 31, 2015 | 23.92B | 917.00M | 3.99% |
Dec 31, 2014 | 23.01B | -3.50B | -13.20% |
Dec 31, 2013 | 26.51B | 74.00M | 0.28% |
Dec 31, 2012 | 26.43B | -956.00M | -3.49% |
Dec 31, 2011 | 27.39B | -1.01B | -3.54% |
Dec 31, 2010 | 28.39B | 24.00M | 0.08% |
Dec 31, 2009 | 28.37B | 4.02B | 16.49% |
Dec 31, 2008 | 24.35B | 1.64B | 7.20% |
Dec 31, 2007 | 22.72B | -509.00M | -2.19% |
Dec 31, 2006 | 23.23B | 1.57B | 7.23% |
Dec 31, 2005 | 21.66B | 1.67B | 8.38% |
Dec 31, 2004 | 19.99B | -1.46B | -6.79% |
Dec 31, 2003 | 21.44B | 229.00M | 1.08% |
Dec 31, 2002 | 21.21B | 677.97M | 3.30% |
Dec 31, 2001 | 20.53B | 2.46B | 13.58% |
Dec 31, 2000 | 18.08B | 9.59B | 112.94% |
Dec 31, 1999 | 8.49B | 507.00M | 6.35% |
Dec 31, 1998 | 7.98B | 3.00M | 0.04% |
Dec 31, 1997 | 7.98B | -361.00M | -4.33% |
Dec 31, 1996 | 8.34B | -2.15B | -20.49% |
Dec 31, 1995 | 10.49B | 4.83B | 85.47% |
Jun 30, 1994 | 5.66B | 726.00M | 14.73% |
Jun 30, 1993 | 4.93B | 834.00M | 20.36% |
Jun 30, 1992 | 4.10B | 699.00M | 20.58% |
Jun 30, 1991 | 3.40B | 218.00M | 6.86% |
Jun 30, 1990 | 3.18B | 609.00M | 23.70% |
Jun 30, 1989 | 2.57B | 511.00M | 24.82% |
Jun 30, 1988 | 2.06B | 318.00M | 18.27% |
Jun 30, 1987 | 1.74B | 312.00M | 21.83% |
Jun 30, 1986 | 1.43B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 37.54B |
Haleon plc | 11.24B |
Smith & Nephew plc | 4.39B |
ConvaTec Group Plc | 1.69B |
Hikma Pharmaceuticals PLC | 2.27B |
Oxford Nanopore Technologies plc | 254.50M |
Animalcare Group plc | 74.35M |
Shell plc | 238.92B |
GSK plc News
- 17 hours ago - Insights Into Merck & Co's Performance Versus Peers In Pharmaceuticals Sector - Benzinga
- 1 day ago - Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by judge - Reuters
- 4 days ago - Insights Into Eli Lilly and Co's Performance Versus Peers In Pharmaceuticals Sector - Benzinga
- 5 days ago - FTSE 100 slips for third day in a row after GSK shares drop - Evening Standard
- 5 days ago - First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product - Benzinga
- 5 days ago - GSK Slumps After CDC Narrows Age Recommendation for RSV Shots - The Wall Street Journal
- 5 days ago - CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK - Benzinga
- 5 days ago - GSK shares fall as US narrows age recommendation for RSV vaccines - Financial Times